About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,800 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,800 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1081-1100 of 10,800 trials

CompletedDiscontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS StudyThe Main Hypothesis of this extension trial is that among those who have successfully discontinued their DMT as part of the DISCOMS trial (i.e. did not have a new MS relapse or…NCT04754542·Aurora, Colorado and 9 others TerminatedStudy of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCTThis is a Phase 1, open-label, non-randomized, single and multiple dose escalation study designed to evaluate the safety and preliminary efficacy of administering Mana 312 to…NCT04679194·Denver, Colorado and 7 others Active not recruitingA Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)This study will determine the effect of oral 80 mg resmetirom administered once daily on participants with well-compensated non-alcoholic steatohepatitis (NASH) cirrhosis by…NCT05500222·Birmingham, Alabama and 140 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedA Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of AgeThis open label study will assess the pharmacokinetics and the safety and tolerability of Valcyte (valganciclovir) powder for oral solution in neonatal and infant heart transplant…NCT01165580·Loma Linda, California and 18 others

CompletedThe PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) AmyloidosisThis is a global, multicenter, Phase 2b, randomized, double-blind, placebo-controlled, two-arm, parallel-group efficacy and safety study of NEOD001 as a single agent administered…NCT02632786·Duarte, California and 39 others

CompletedCombination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaThis randomized phase III trial is studying different combination chemotherapy regimens and their side effects and comparing how well they work in treating young patients with…NCT00408005·Birmingham, Alabama and 214 others

CompletedA Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerThis is a multicenter, global, Phase 2, open-label, 2-part, first-line study to investigate the safety, tolerability, and anti-tumor activity of ZW25 (zanidatamab) plus standard…NCT03929666·Los Angeles, California and 22 others

CompletedA Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung CancerA Phase 1-2 study of MM-121 in combination with standard therapy for non-small cell lung cancer (NSCLC).NCT00994123·Birmingham, Alabama and 37 others

CompletedInpatient Influenza SurveillanceInfluenza vaccination is recommended for all persons age 65 and older.NCT00419861·Nashville, Tennessee

CompletedA Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic MelanomaThis is an open-label, multicenter, Phase Ib, dose-escalation and cohort-expansion study of atezolizumab (anti-programmed death-ligand 1 \[PD-L1\] antibody) in combination with…NCT01656642·Los Angeles, California and 7 others

RecruitingEvaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric InsomniaThis is a multicenter, double-blind, randomized study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon and matching placebo in male and female…NCT06953869·Dothan, Alabama and 34 others

CompletedMulticenter Orthopaedic Outcomes Network (MOON) ACL Reconstruction (ACLR): Onsite Follow-upIn this study we will examine patients who have undergone unilateral ACL reconstruction surgery to determine which structural and functional characteristics of the knee two and…NCT00478894·St Louis, Missouri and 3 others

RecruitingMinimally Invasive Neuroendoscopic Ultra-Early Targeted ICH EvacuationMINUTE is a prospective, multi-center, randomized, controlled, blinded assessor, adaptive enrichment design, clinical trial.NCT07260916·Phoenix, Arizona and 43 others

TerminatedTreatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148Septic shock is a potentially life-threatening condition that can result in multi-organ dysfunction syndrome (MODS) and mortality.NCT02317549·Mobile, Alabama and 33 others

Active not recruitingMobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep StudyThis phase III trial compares a multi-component mobile health and social media physical activity intervention versus wearing a physical activity tracker alone among adolescent and…NCT04089358·Mobile, Alabama and 115 others

RecruitingIDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic CancersThis is an open label, Phase 1/2, first-in-human, multiple ascending dose, and dose-expansion study of IDP-023 administered as a single agent and in combination with or without…NCT06119685·Los Angeles, California and 11 others

TerminatedLiposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AMLThis is a Phase I, multi-center, open-label, dose escalation, MTD study of liposomal annamycin in children and young adults with refractory or relapsed ALL or AML.NCT00430443·Phoenix, Arizona and 2 others

RecruitingA Phase 3 Efficacy and Safety Study of HBS-301 in Participants With NarcolepsyThis is a Phase 3, multicenter, randomized, double-blind, parallel-group, placebo-controlled clinical study to assess the efficacy and safety of HBS-301 in treating excessive…NCT07675135·Birmingham, Alabama and 52 others

RecruitingA Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid TumorsThis is a first in human (FIH), Phase 1, dose escalation and expansion study in select solid tumors.NCT07612176·New York, New York and 8 others

CompletedA Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine AttackIntraject is a needle-free, single use, disposable, subcutaneous delivery system pre-filled with 6mg Sumatriptan to be used by patients to treat acute migraine treatment.NCT00530517·Chicago, Illinois and 3 others

PreviousPage 55 of 540Next

Diabetes

in Nashville

Heart Diseasein Nashville